Feed type
Linkedin
Post created date
1727902806
Post ID
urn:li:share:7247349650762964993
Patients with Inappropriate Sinus Tachycardia (IST) often experience symptoms that significantly impact their quality of life. For those who don’t respond to or are intolerant to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment.
Learn more about the study: heal-ist.com
<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Innapropriatesinustachy…; target='_blank'>#Innapropriatesinustachycardia</a>
Post image URL
https://media.licdn.com/dms/image/v2/D5610AQGBVv9fT89Jpw/image-shrink_800/image-shrink_800/0/1727902803534?e=1728691200&v=beta&t=2O6BIA1UH934S2JmghZ2dpw7OL68uRZahmZN5RIC8Ec
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7247349650762964993
Post creted timestamp
